These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Infectious markers in blood donors of East Delhi: prevalence and trends. Singh B; Kataria SP; Gupta R Indian J Pathol Microbiol; 2004 Oct; 47(4):477-9. PubMed ID: 16295370 [TBL] [Abstract][Full Text] [Related]
4. Transfusion-transmitted diseases: current problems and challenges. Bove JR Prog Hematol; 1986; 14():123-47. PubMed ID: 3003795 [No Abstract] [Full Text] [Related]
5. [Complications in blood transfusion. 2. Infections transmitted by blood and blood products]. Lehmann H Intensivmed Prax; 1982 Jun; 5():93-108. PubMed ID: 6295962 [No Abstract] [Full Text] [Related]
6. Transfusion-transmitted diseases other than AIDS and hepatitis. Bove JR Yale J Biol Med; 1990; 63(5):347-51. PubMed ID: 1963503 [TBL] [Abstract][Full Text] [Related]
7. Decreasing risk of viral transfusion-transmitted diseases in Croatia. Grgicević D; Balija M; Pirc-Tiljak D; Mihaljević I; Gjenero-Margan I; Zupancić-Salek S; Macek P Croat Med J; 2000 Jun; 41(2):191-6. PubMed ID: 10853051 [TBL] [Abstract][Full Text] [Related]
8. [Infection risk caused by blood or blood products]. Gürtler L; Schramm W Dtsch Med Wochenschr; 1993 Apr; 118(14):520-2. PubMed ID: 7741799 [No Abstract] [Full Text] [Related]
9. [Risks of transfusions with blood and blood products]. van Aken WG; Engelfriet CP Ned Tijdschr Geneeskd; 1984 Nov; 128(44):2095-9. PubMed ID: 6095122 [No Abstract] [Full Text] [Related]
10. The risks of transfusion-transmitted infection: direct estimation and mathematical modelling. Kleinman SH; Busch MP Baillieres Best Pract Res Clin Haematol; 2000 Dec; 13(4):631-49. PubMed ID: 11102281 [TBL] [Abstract][Full Text] [Related]
11. [The role of the Ministry of Health in the prevention of diseases caused by blood transfusion]. Wolpert Barraza E; Córdova MS; Robles Díaz G; Reyes López PA Gac Med Mex; 1994; 130(6):412-24. PubMed ID: 7557054 [No Abstract] [Full Text] [Related]
13. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy. Gonzalez M; Règine V; Piccinini V; Vulcano F; Giampaolo A; Hassan HJ Transfusion; 2005 Oct; 45(10):1670-5. PubMed ID: 16181219 [TBL] [Abstract][Full Text] [Related]
14. Infectious pathogens in volunteer and replacement blood donors in Pakistan: a ten-year experience. Sultan F; Mehmood T; Mahmood MT Int J Infect Dis; 2007 Sep; 11(5):407-12. PubMed ID: 17331775 [TBL] [Abstract][Full Text] [Related]
15. Transfusion-transmitted viruses. Wright-Kanuth MS; Smith LA Clin Lab Sci; 2003; 16(4):221-9. PubMed ID: 14626440 [No Abstract] [Full Text] [Related]
16. Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus. Seed CR; Kiely P; Keller AJ Intern Med J; 2005 Oct; 35(10):592-8. PubMed ID: 16207258 [TBL] [Abstract][Full Text] [Related]
17. [Viral safety of blood and blood products]. Gürtler L Fortschr Med; 1993 Nov; 111(33):526-7. PubMed ID: 8307536 [No Abstract] [Full Text] [Related]